Skip to content
Vivo logo
← All articles

Sermorelin Side Effects: What Is Common, What Is Not, and What to Ask

Sermorelin Side Effects: What Is Common, What Is Not, and What to Ask

Abstract illustration of evidence and uncertainty

Most sermorelin side effects are mild and limited to the injection site: pain, redness, swelling or itching. Flushing, headache, dizziness and sleepiness are also listed. Serious allergic reactions are uncommon but need emergency care. The larger open question for adults using sermorelin for anti-aging is not a single symptom. It is that long-term safety and benefit in healthy adults have not been well established, and that most sermorelin dispensed today is compounded rather than an FDA-approved commercial product.

This guide separates documented short-term effects from warning signs, explains what is and is not known about long-term use, and lists what to ask a prescriber and a pharmacy. It is general information, not a substitute for individual medical advice.

Vivo ClinicExplore Sermorelin With Medical GuidanceVivo Clinic offers provider-supervised Sermorelin treatment with personalized selection and precision-compounded therapies prepared by licensed U.S. pharmacies.Explore treatment options

TL;DR

  • Common effects are injection-site pain, redness, swelling or itching, plus occasional flushing, headache, dizziness and sleepiness, according to Mayo Clinic’s drug reference.
  • Emergency signs include hives, swelling of the lips, tongue or face, shortness of breath, chest tightness or trouble swallowing. Call 911 rather than waiting for a message reply.
  • Long-term safety in healthy adults using sermorelin off-label is not well established, and the benefits have not been confirmed in large randomized trials.
  • Pharmacy quality is part of the safety profile. Ask who prescribes, which pharmacy compounds, and how recalls are communicated.
  • Competitive athletes should know sermorelin is prohibited under anti-doping rules.

Table of Contents

What sermorelin is, and why its status matters for safety

Sermorelin is a synthetic fragment of growth hormone-releasing hormone. It signals the pituitary gland to release the body’s own growth hormone, rather than supplying growth hormone directly. Scientific American reports that the FDA approved sermorelin in 1997 to treat growth hormone deficiency in children, and that it was later discontinued and withdrawn for commercial reasons.

That history shapes how to read safety information. Much of the documented tolerability comes from pediatric treatment of diagnosed deficiency. Using sermorelin in healthy adults for energy, body composition or aging is generally off-label, so pediatric evidence cannot be treated as proof of long-term safety in that setting. Sermorelin available in the United States today may be compounded by a pharmacy against an individual prescription, which is lawful when done under the applicable compounding rules, but the FDA does not review a compounded product for safety or effectiveness the way it reviews an approved drug.

Common sermorelin side effects

The clinical reference most readers are directed to is Mayo Clinic’s. It lists these effects for the injection:

  • Pain, redness, swelling or itching at the injection site
  • Dizziness
  • Facial flushing
  • Headache
  • Sleepiness
  • Difficulty sitting still

The Mayo Clinic listing advises contacting a healthcare professional if symptoms persist or become bothersome. It does not give incidence percentages, and it does not show that every compounded formulation has the same frequency profile. Any article that quotes a precise percentage for adult wellness use should be read with caution, because no authoritative universal figure exists in the sources we reviewed.

Injection-site reactions

These are the most consistently reported. They usually involve a small area of redness, mild tenderness or itching where the subcutaneous injection was given. Rotating sites and following the technique the prescriber demonstrated are the usual first steps. A reaction that spreads, blisters, drains, or comes with fever should be reported to the prescriber promptly, because it may signal infection or a reaction to an ingredient rather than routine irritation.

Flushing, headache, dizziness and sleepiness

These are systemic effects that tend to be brief. Because sermorelin is often dosed in the evening, sleepiness is one reason timing is discussed with the prescriber. Dizziness deserves a little extra attention in people who take blood pressure or diabetes medication, since the combined effect should be reviewed by a clinician.

Other effects described in clinical summaries

A 2026 safety review also describes possible nausea, rash and taste changes, while stressing that adult long-term evidence is limited. These are less commonly reported than injection-site effects.

Symptoms that need a clinician’s review

Some symptoms should not be dismissed as the body adjusting. They point to either excessive growth hormone signaling or a problem with the product or the patient’s health profile.

Symptom Why it matters Who to contact
Persistent injection-site redness, swelling or pain May be irritation, infection or ingredient sensitivity Prescribing team
Swelling in the hands, feet, arms, legs or face that progresses Fluid retention is associated with growth hormone excess Prescribing team the same week
Tingling in the hands, joint or nerve pain Also associated with excess growth hormone Prescribing team
Unusual thirst, frequent urination, new fatigue Possible glucose changes Prescribing team or primary care
Marked change in blood pressure Hypertension is a listed concern with growth hormone excess Prescribing team or primary care
Hives, swelling of lips, tongue or face, trouble breathing, chest tightness, trouble swallowing Possible serious allergic reaction Call 911

The USADA review of sermorelin notes that users commonly report swelling and edema in the arms, legs and face, along with joint and nerve pain, and that excess growth hormone may be associated with insulin resistance, hypertension and cardiac effects. These are reasons for monitoring, not evidence that every user will experience them.

For allergic reactions, Healthline’s medically reviewed summary identifies airway, facial-swelling and chest symptoms as signs that call for emergency assessment. A telehealth message queue is the wrong channel for those. Routine symptoms go to the prescribing team; breathing difficulty or rapidly progressing facial or throat swelling goes to emergency services.

Sermorelin long-term effects and risks

This is where honesty matters most. Healthline states that long-term risks of sermorelin are not known, even though it is usually well tolerated in the short term. The same gap appears in recent reporting: a University of Utah urologist, Alexander Pastuszak, told Scientific American that sermorelin is known to raise growth hormone, but large randomized trials in healthy adults have not tested whether it improves performance, body composition or longevity.

So the decision is not only whether a side effect is possible. It is whether an uncertain adult benefit justifies the exposure, and whether a licensed prescriber is monitoring you while you find out. Growth hormone and IGF-1 are involved in cell growth, which is why researchers discuss theoretical long-term concerns, but no authoritative source we reviewed establishes a specific long-term outcome for adult wellness use. Anyone with a history of cancer should raise it explicitly during screening.

For related context on how long-term evidence is developing, see our overview of peptides for longevity and the timing of ongoing trials.

Sermorelin long-term effects and risks — overview diagram

Who should be screened before starting

A prescriber should review your history before sermorelin is prescribed. Based on Mayo Clinic’s guidance and the clinical summaries we reviewed, the topics include:

  • Untreated hypothyroidism
  • Diabetes or prediabetes
  • Pituitary or hypothalamic disease
  • Pregnancy or breastfeeding
  • Allergy history
  • Cancer history
  • All prescription drugs, over-the-counter products and supplements, especially thyroid medicines, insulin, glucocorticoids, aspirin and drugs that affect somatostatin or pituitary signaling

Use only the prescribed amount and frequency. The Mayo Clinic reference specifically warns that using more increases the risk of side effects. No authoritative universal adult anti-aging dose exists in the sources cited, so dose and monitoring must be set individually by the licensed prescriber. A telehealth intake form is not a substitute for honest disclosure: the screening only works if the list is complete.

Is sermorelin safe? The pharmacy question

For injectables, the manufacturing source is part of the safety profile. Two FDA records illustrate why.

  • In March 2022, a compounding pharmacy recalled specific lots of compounded injectables, including two 9-mg sermorelin lots found out of specification. The lots had best-use dates of April 26, 2022 and June 4, 2022. Those dates concern the recalled lots, not a universal expiration rule.
  • An FDA inspection report from April 2025 describes a facility that prepared sermorelin among other injectables, and records observations about sterile compounding practices.

An FDA letter from 2019 also stated that sermorelin bulk substance was not eligible for the cited section 503B exemption at that time. The practical lesson is not that all compounded sermorelin is unsafe. It is that quality varies by pharmacy, and you are entitled to ask.

Questions to ask before you accept a prescription

  • Who is the prescriber, and are they licensed in my state?
  • Which pharmacy compounds the medication, and is it a 503A pharmacy or a 503B outsourcing facility?
  • How are sterility and potency tested?
  • How will I be told if a lot is recalled?
  • Who do I contact, and how fast, if I have a reaction?

Keep the vial, lot number, beyond-use date and pharmacy contact information, so that a recall or quality concern can be acted on quickly. Our articles on who prescribes peptides in the U.S. and on 503A versus 503B shipments go deeper on both questions.

Extra considerations for athletes and fitness-focused adults

People with consistent training routines are a large share of those researching sermorelin, and one issue is specific to them. USADA identifies sermorelin as prohibited under anti-doping rules because it can stimulate endogenous growth hormone. A valid prescription does not change that. If you compete in a sanctioned event, check your sport’s governing body before starting, and ask whether a therapeutic use exemption is even relevant.

Our perspective on sermorelin safety

We prescribe and dispense sermorelin through a telehealth model, so we hold ourselves to the same questions we suggest you ask. Short-term tolerability is reasonably documented. Long-term outcomes in healthy adults are not, and we think patients deserve to hear that plainly rather than discover it later.

Our perspective on sermorelin safety — overview diagram

Three things follow from that. First, a licensed provider should review history and medications before any prescription is written, and oversight should continue after the first shipment, not end at checkout. Second, patients should know which U.S. pharmacy compounds their medication and should be able to ask about it. Third, reactions should be easy to report: routine ones to the prescribing team, emergencies to 911.

We would also rather a patient decide not to start than start without understanding the evidence gap. Sermorelin is one option among several, and for some people the right answer after screening is a different therapy or none.

— Jack

Sermorelin through Vivo Clinic

Our sermorelin plan is a prescription therapy compounded by a licensed U.S. pharmacy and delivered to your door, at 139 USD per month. Treatment begins with a HIPAA-compliant telehealth intake and a provider’s review of your history. A provider decides whether sermorelin is appropriate, and supervision continues while you are on the plan. Approval is not guaranteed, and the decision depends on your medical history.

If you are comparing it with another growth hormone secretagogue, our write-ups on CJC-1295 and sermorelin and sermorelin and ipamorelin set out what the research does and does not show.

Frequently asked questions

Do sermorelin side effects go away?

Injection-site reactions, flushing, headache and dizziness are typically short-lived, and many people find they ease as technique improves. Mayo Clinic advises contacting a healthcare professional if symptoms persist or become bothersome. Progressive swelling, tingling or joint pain should be reviewed by the prescriber rather than waited out.

Is sermorelin safe for long-term use?

The honest answer is that long-term safety in healthy adults has not been established. Short-term use appears generally tolerated, but most evidence comes from pediatric treatment of growth hormone deficiency, which cannot be used as proof for adult anti-aging use. If you use it, ongoing provider monitoring matters more than any single reassurance.

What are the most serious sermorelin risks?

The most urgent is a serious allergic reaction: hives, swelling of the lips, tongue or face, breathing difficulty, chest tightness or trouble swallowing. Call 911. Other concerns include fluid retention, glucose changes and blood pressure changes from excess growth hormone signaling, plus quality problems with an improperly compounded injectable.

Can I take sermorelin if I have a thyroid condition or diabetes?

Untreated hypothyroidism, diabetes or prediabetes, and medications such as thyroid drugs, insulin and glucocorticoids are among the items a prescriber should review before treatment. This is a decision for a licensed provider based on your records, not something to settle from an article.

Sources